ICY:FRA
Incyte Corp
95,98 €
arrow_downward
-1,66%(-1,62) 1D
14 հոկ, 08:01:16 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
95,98 €
High
95,98 €
Low
95,98 €
Mkt. cap
22,02 մլրդ
Avg. vol.
34,00
Volume
0,00
52-wk high
115,40 €
52-wk low
72,28 €
No. of employees
3 հզր
Open
95,98 €
High
95,98 €
Low
95,98 €
Mkt. cap
22,02 մլրդ
Avg. vol.
34,00
Volume
0,00
52-wk high
115,40 €
52-wk low
72,28 €
No. of employees
3 հզր
News stories
From web sources and news partners
The Globe and Mail
·
3 ժամ առաջ
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)
Yahoo Finance
·
19 ժամ առաջ
Incyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) Community
Investing.com
·
1 օր առաջ
Incyte stock price target maintained at $152 by H.C. Wainwright
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 հզր
Founded2002
HeadquartersՈւիլմինգտոն, Դելավեր, Միացյալ Նահանգներ
Sector-
Websiteincyte.com